181 related articles for article (PubMed ID: 20017609)
1. Pharmacological inhibition of phosphoinositide 3 and TOR kinases improves survival of Drosophila melanogaster.
Moskalev AA; Shaposhnikov MV
Rejuvenation Res; 2010; 13(2-3):246-7. PubMed ID: 20017609
[TBL] [Abstract][Full Text] [Related]
2. [Longevity extension by specific inhibition of pI3K in Drosophila melanogaster].
Moskalev AA; Shaposhnikov MV
Adv Gerontol; 2008; 21(4):602-6. PubMed ID: 19432212
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological PI 3-kinase inhibitors induce radioprotective effect in Drosophila melanogaster imago].
Shaposhnikov MV; Danilov AA; Moskalev AA
Radiats Biol Radioecol; 2010; 50(6):649-55. PubMed ID: 21434391
[TBL] [Abstract][Full Text] [Related]
4. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
Brunn GJ; Williams J; Sabers C; Wiederrecht G; Lawrence JC; Abraham RT
EMBO J; 1996 Oct; 15(19):5256-67. PubMed ID: 8895571
[TBL] [Abstract][Full Text] [Related]
5. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production.
Salh B; Wagey R; Marotta A; Tao JS; Pelech S
J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.
Chen T; Shen L; Yu J; Wan H; Guo A; Chen J; Long Y; Zhao J; Pei G
Aging Cell; 2011 Oct; 10(5):908-11. PubMed ID: 21615676
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin enhances survival in a Drosophila model of mitochondrial disease.
Wang A; Mouser J; Pitt J; Promislow D; Kaeberlein M
Oncotarget; 2016 Dec; 7(49):80131-80139. PubMed ID: 27741510
[TBL] [Abstract][Full Text] [Related]
9. LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects calcium signaling in airway smooth muscle cells independently of phosphoinositide 3-kinase inhibition.
Tolloczko B; Turkewitsch P; Al-Chalabi M; Martin JG
J Pharmacol Exp Ther; 2004 Nov; 311(2):787-93. PubMed ID: 15194708
[TBL] [Abstract][Full Text] [Related]
10. PI3-kinase and mTOR inhibitors differently modulate the function of the ABCG2 multidrug transporter.
Hegedüs C; Truta-Feles K; Antalffy G; Brózik A; Kasza I; Német K; Orbán TI; Özvegy-Laczka C; Váradi A; Sarkadi B
Biochem Biophys Res Commun; 2012 Apr; 420(4):869-74. PubMed ID: 22449574
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster.
Bjedov I; Toivonen JM; Kerr F; Slack C; Jacobson J; Foley A; Partridge L
Cell Metab; 2010 Jan; 11(1):35-46. PubMed ID: 20074526
[TBL] [Abstract][Full Text] [Related]
12. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B.
Lizcano JM; Alrubaie S; Kieloch A; Deak M; Leevers SJ; Alessi DR
Biochem J; 2003 Sep; 374(Pt 2):297-306. PubMed ID: 12841848
[TBL] [Abstract][Full Text] [Related]
13. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
Bishop JD; Nien WL; Dauphinee SM; Too CK
J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
[TBL] [Abstract][Full Text] [Related]
14. Regulation of translation initiation by FRAP/mTOR.
Gingras AC; Raught B; Sonenberg N
Genes Dev; 2001 Apr; 15(7):807-26. PubMed ID: 11297505
[No Abstract] [Full Text] [Related]
15. Bone morphogenetic protein-2-induced transformation involves the activation of mammalian target of rapamycin.
Langenfeld EM; Kong Y; Langenfeld J
Mol Cancer Res; 2005 Dec; 3(12):679-84. PubMed ID: 16380505
[TBL] [Abstract][Full Text] [Related]
16. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
17. New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs).
Feldman ME; Shokat KM
Curr Top Microbiol Immunol; 2010; 347():241-62. PubMed ID: 20549474
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I inhibits rat arterial K(ATP) channels through pI 3-kinase.
Hayabuchi Y; Willars GB; Standen NB; Davies NW
Biochem Biophys Res Commun; 2008 Oct; 374(4):742-6. PubMed ID: 18671941
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
20. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors.
Takeuchi H; Kondo Y; Fujiwara K; Kanzawa T; Aoki H; Mills GB; Kondo S
Cancer Res; 2005 Apr; 65(8):3336-46. PubMed ID: 15833867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
